In Treatment of Malaria Clokit Junior Kit is used to treat malaria, a serious or life-threatening illness that is spread by a parasite that enters the human body by the bite of infected mosquitoes. It kills the infection causing parasite and stops further spread of the infection. Take it only as prescribed and refrain from taking any other medicines along with this medicine (unless advised by the doctor) as they may affect the absorption of this medicine. Do not use this medicine for treating any other condition without consulting your doctor.
It is not known whether it is safe to consume alcohol with Clokit Junior Kit. Please consult your doctor.
Clokit Junior Kit may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Clokit Junior Kit is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Clokit Junior Kit may cause side effects which could affect your ability to drive. Sometimes Clokit Junior Kit causes blurred eyesight or makes it difficult to focus your eyes which may affect your ability to drive.
Clokit Junior Kit should be used with caution in patients with kidney disease. Dose adjustment of Clokit Junior Kit may be needed. Please consult your doctor.
Clokit Junior Kit should be used with caution in patients with liver disease. Dose adjustment of Clokit Junior Kit may be needed. Please consult your doctor. Regular monitoring of liver function tests may be advised while you are taking this medicine.
If you miss a dose of Clokit Junior Kit, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More